DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE Amex: NAVB) today announced that Dr. Mark Pykett, President and Chief Executive Officer, will participate at the 14th Annual BIO CEO & Investor Conference, hosted by the Biotechnology Industry Organization (BIO), on February 13-14 at the Waldorf Astoria in New York City. Dr. Pykett will provide an update of the Company and its development programs on Monday February 13, 2012 at 11:30 AM EST.
